Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV
- PMID: 38814718
- DOI: 10.1097/QAD.0000000000003902
Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV
Comment in
-
Towards a refined understanding of cerebrospinal fluid CXCL13 in neurosyphilis diagnosis among people with HIV.AIDS. 2024 Jul 1;38(8):1275-1278. doi: 10.1097/QAD.0000000000003901. Epub 2024 May 30. AIDS. 2024. PMID: 38814719 No abstract available.
Comment on
-
Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV.AIDS. 2024 Apr 1;38(5):657-668. doi: 10.1097/QAD.0000000000003813. Epub 2023 Dec 11. AIDS. 2024. PMID: 38079581
Similar articles
-
Towards a refined understanding of cerebrospinal fluid CXCL13 in neurosyphilis diagnosis among people with HIV.AIDS. 2024 Jul 1;38(8):1275-1278. doi: 10.1097/QAD.0000000000003901. Epub 2024 May 30. AIDS. 2024. PMID: 38814719 No abstract available.
-
CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.Sex Transm Dis. 2010 May;37(5):283-7. doi: 10.1097/OLQ.0b013e3181d877a1. Sex Transm Dis. 2010. PMID: 20393380 Free PMC article.
-
Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.Int J STD AIDS. 2016 Feb;27(2):141-6. doi: 10.1177/0956462415577229. Epub 2015 Mar 12. Int J STD AIDS. 2016. PMID: 25769888
-
Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.Int J Mol Sci. 2020 Apr 22;21(8):2927. doi: 10.3390/ijms21082927. Int J Mol Sci. 2020. PMID: 32331231 Free PMC article. Review.
-
Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.BMJ Open. 2024 May 31;14(5):e078527. doi: 10.1136/bmjopen-2023-078527. BMJ Open. 2024. PMID: 38821573 Free PMC article.
References
-
- Carvalho RS, Rangel IC, Soane MM, Bacarov NBS, Herbst V, Ferry FRA. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV . AIDS 2024; 38:657–668.
-
- Cohen KW, Dugast A-S, Alter G, McElrath MJ, Stamatatos L. HIV-1 single-stranded RNA induces CXCL13 secretion in human monocytes via TLR7 activation and plasmacytoid dendritic cell-derived type I IFN . J Immunol 2015; 194:2769–2775.
-
- Widney DP, Breen EC, Boscardin WJ, Kitchen SG, Alcantar JM, Smith JB, et al. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection . J Interferon Cytokine Res 2005; 25:702–706.
-
- Trunfio M, Mighetto L, Napoli L, Atzori C, Nigra M, Guastamacchia G, et al. Cerebrospinal fluid CXCL13 as candidate biomarker of intrathecal immune activation, IgG synthesis and neurocognitive impairment in people with HIV . J Neuroimmune Pharmacol 2023; 18:169–182.
-
- DiSano KD, Gilli F, Pachner AR. Intrathecally produced CXCL13: a predictive biomarker in multiple sclerosis . Mult Scler J Exp Transl Clin 2020; 6:2055217320981396.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical